Effect of N-acetyl cysteine supplementation versus placebo on clinical outcomes in women with chronic pelvic pain syndrome
Phase 3
Not yet recruiting
- Conditions
- Chronic pelvic pain syndrome.Pelvic and perineal painR10.2
- Registration Number
- IRCT20120215009014N376
- Lead Sponsor
- Hamedan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Female
- Target Recruitment
- 60
Inclusion Criteria
Age of 18 to 50 years,
Women with chronic pelvic pain syndrome for at least 6 months,
Exclusion Criteria
Presence of pathologic or infamous reason for chronic pelvic pain,
Mild symptoms (the score less than 15 based on NIH-CPSI questionnaire),
Chronic liver or renal disease,
Kidney stone or urogenital tract infection,
History of surgery of urogenital tract,
Contraindication of N-acetyl cysteine
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinical symptoms. Timepoint: Before the intervention and 4 and 8 weeks after that. Method of measurement: Using the National Institutes of Health - Chronic Prostatitis Symptom Index (NIH-CPSI) standard questionnaire.
- Secondary Outcome Measures
Name Time Method